Cent Eur J Public Health 2022, 30(4):265-267 | DOI: 10.21101/cejph.a7643

Death from COVID-19 of a 57-year-old man refusing medical care and self-medicating with ivermectin

Robin Šín1, 2, Miroslav Kubiska1
1 Department of Infectious Diseases and Travel Medicine, Faculty of Medicine in Pilsen, Charles University, Faculty Hospital Pilsen, Pilsen, Czech Republic
2 Emergency Medical Service of the Pilsen Region, Pilsen, Czech Republic

Since December 2019, the new SARS-CoV-2 coronavirus causes COVID-19 disease worldwide, which occurs mainly in unvaccinated elderly and polymorbid patients with a more severe course and increased risk of complications and death. Vaccination and specific therapy for the disease using mainly new antiviral drugs are the way to reduce the number of infected, hospitalized patients with a more severe course. We present a case report of an at-risk polymorbid 57-year-old man who refused vaccination and standard treatment for COVID-19 disease based on misinformation from the community. He self-treated himself with high dose of ivermectin. The patient died at home 14 days after the onset of symptoms.

Keywords: COVID-19, ivermectin, misinformation, refusing medical care

Received: October 31, 2022; Revised: December 23, 2022; Accepted: December 23, 2022; Published: December 31, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šín R, Kubiska M. Death from COVID-19 of a 57-year-old man refusing medical care and self-medicating with ivermectin. Cent Eur J Public Health. 2022;30(4):265-267. doi: 10.21101/cejph.a7643. PubMed PMID: 36718931.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wassie GT, Azene AG, Bantie GM, Dessie G, Aragaw AM. Incubation period of severe acute respiratory syndrome novel coronavirus 2 that causes coronavirus disease 2019: a systematic review and meta-analysis. Cur Ther Res Clin Exp. 2020;93:100607. doi: 10.1016/j.curtheres.2020.100607. Go to original source... Go to PubMed...
    2. Akoumianaki E, Vaporidi K, Bolaki M, Georgopoulos D. Happy or silent hypoxia in COVID-19 - a misnomer born in the pandemic era. Front Physiol. 2021 Oct 18;12:745634. doi: 10.3389/fphys.2021.745634. Go to original source... Go to PubMed...
    3. Hill A, Mirchandani M, Pilkington V. Ivermectin for COVID-19: addressing potential bias and medical fraud. Open Forum Infect Dis. 2022 Feb;9(2):ofab645. doi: 10.1093/ofid/ofab645. Go to original source... Go to PubMed...
    4. Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med. 2020 Nov 5;383(19):1827-37. Go to original source... Go to PubMed...
    5. Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, et al. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA. 2020 Sep 15;324(11):1048-57. Go to original source... Go to PubMed...
    6. RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693-704. Go to original source... Go to PubMed...
    7. Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J. 2021;42(23):2270-9. Go to original source... Go to PubMed...
    8. Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res. 2020 Aug 31;8:37. doi: 10.1186/s40364-020-00217-0. Go to original source... Go to PubMed...
    9. Džupová O, Moravec M, Bartoš H, Brestovanský P, Tencer T, Hyánek T, et al. COVID-19 severe pneumonia: prospective multicentre study on demands on intensive care capacities. Cent Eur J Public Health. 2021 Mar;29(1):3-8. Go to original source... Go to PubMed...
    10. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020 Jul 9;383(2):120-8. Go to original source... Go to PubMed...

    Return to the content